Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: tool dude who wrote (121110)	10/16/2003 7:58:52 PM
From: StockDung	Respond to of 150070

Yup, also this This is G o o g l e's cache of fengshuiconsultinginc.com. G o o g l e's cache is the snapshot that we took of the page as we crawled the web. The page may have changed since that time. Click here for the current page without highlighting. To link to or bookmark this page, use the following url: google.com Google is not affiliated with the authors of this page nor responsible for its content. These search terms have been highlighted: stem genetics inc -------------------------------------------------------------------------------- References/Projects US Dataworks, Inc. (fka Sonicport) H-net.net, Inc Juniper Group, Inc. Stem Genetics, Inc. - website: www.stemgenetics.net

To: tool dude who wrote (121110)	10/16/2003 8:06:21 PM
From: StockDung	Respond to of 150070

Ari Ma'ayan->Stem Genetics Advisory Staff & Management web.archive.org -------------------------------------------------------------------------------- Robert L. Youngblood, M.D.: President click here Ari Ma'ayan: Corporate Structuring & Technology Development Advisory Consultant. click here Jeffrey L. Garwin, M.D., Ph.D.: Scientific Advisory Consultant. click here Terry Michael DeRouin: Scientific Advisory Consultant. click here Craig W. Morrison, M.D.: Scientific Advisory Consultant. click here Shohreh Iravani, M.D.: Scientific Advisory Consultant. click here Investor Relations -------------------------------------------------------------------------------- National Financial Communications click here Investor Relations Specialist: Clint Marchant @ (801) 631-9681 or via e-mail at clint_marchant@NationalFC.com

To: tool dude who wrote (121110)	10/16/2003 8:08:30 PM
From: StockDung	Respond to of 150070

Ari Ma’ayan, Director. Mr. Ma’ayan has been with Biomoda, Inc. since 1990 as a director. He was President from January 1990 until December 2001. Mr. Ma’ayan has served as Vice President for RhoMed, Inc. (1/88-1/90), biotech company specializing in radio labeling of monoclonal antibodies, ChemBioMed, Inc. (12/85-1/88), a R&D company creating synthetic oligosaccharides, and President of American BioDesign, Inc.(10/83-12/85), a biotech consulting company specializing in R&D scale-up and production of biologics and recombinant organisms. He held senior staff positions at Biogen, Inc., a contract pilot production facility, and Genzyme Corp., an R&D biochemical facility. Mr. Ma’ayan’s academic experience includes a research and development assignment with the Hebrew University School of Medicine where from 1973 to 1980 he participated in the creation of a biotechnology facility related to fermentation. He received a $500,000 grant from the Canadian National Research in 1986 for cell culture research and served on a "Distinguished Scientists Advisory panel" working with the Division of Biological Sciences. He also received a Phase I SBIR from the National Institute for Health in 1989 for developing a diagnostic.